261 related articles for article (PubMed ID: 8402755)
1. Serial changes in plasma concentration of plasminogen activator inhibitor-1 before and serially after thrombolytic therapy for acute myocardial infarction.
Goto S; Kawai Y; Handa S; Abe S; Takahashi E; Watanabe K; Hori S; Ikeda Y
Cardiology; 1993; 82(4):280-5. PubMed ID: 8402755
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the fibrinolytic system components during acute myocardial infarction.
Ioannidou-Papayannaki E; Lefkos N; Boudonas G; Efthimiadis A; Psirropoulos D; Vogas V; Papadopoulos I; Klonizakis I
Acta Cardiol; 2000 Aug; 55(4):247-53. PubMed ID: 11041123
[TBL] [Abstract][Full Text] [Related]
3. Rebound increase of plasminogen activator inhibitor type I after cessation of thrombolytic treatment for acute myocardial infarction is independent of type of plasminogen activator used.
Genser N; Lechleitner P; Maier J; Dienstl F; Artner-Dworzak E; Puschendorf B; Mair J
Clin Chem; 1998 Feb; 44(2):209-14. PubMed ID: 9474013
[TBL] [Abstract][Full Text] [Related]
4. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.
Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ
Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462
[TBL] [Abstract][Full Text] [Related]
5. The role of type-1 plasminogen activator inhibitor in failure of thrombolytic therapy with recombinant tissue plasminogen activator.
Huber K; Beckmann R; Rauscha F; Probst P; Kaindl F; Binder BR
Z Kardiol; 1993; 82 Suppl 2():195-200. PubMed ID: 8328203
[TBL] [Abstract][Full Text] [Related]
6. Concurrent nitroglycerin therapy impairs tissue-type plasminogen activator-induced thrombolysis in patients with acute myocardial infarction.
Nicolini FA; Ferrini D; Ottani F; Galvani M; Ronchi A; Behrens PH; Rusticali F; Mehta JL
Am J Cardiol; 1994 Oct; 74(7):662-6. PubMed ID: 7942523
[TBL] [Abstract][Full Text] [Related]
7. Plasma TAFI and soluble CD40 ligand do not predict reperfusion following thrombolysis for acute myocardial infarction.
Cruden NL; Graham C; Harding SA; Ludlam CA; Fox KA; Newby DE
Thromb Res; 2006; 118(2):189-97. PubMed ID: 16055173
[TBL] [Abstract][Full Text] [Related]
8. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.
Soeki T; Tamura Y; Fukuda N; Ito S
Jpn Circ J; 2000 Aug; 64(8):547-53. PubMed ID: 10952148
[TBL] [Abstract][Full Text] [Related]
9. Regulation of tissue-type plasminogen activator-mediated fibrinolysis by plasminogen activator inhibitor type-1 in patients with ischaemic heart disease: possible unfavourable effect of diuretics.
Pedersen OD; Gram J; Bagger H; Keller N; Jespersen J
Coron Artery Dis; 1994 Jul; 5(7):617-23. PubMed ID: 7952424
[TBL] [Abstract][Full Text] [Related]
10. Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarction.
Pedersen OD; Gram J; Jeunemaitre X; Billaud E; Jespersen J
Coron Artery Dis; 1997 May; 8(5):283-91. PubMed ID: 9285181
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor type-1 (part two): role for failure of thrombolytic therapy. PAI-1 resistance as a potential benefit for new fibrinolytic agents.
Huber K
J Thromb Thrombolysis; 2001 May; 11(3):195-202. PubMed ID: 11577257
[TBL] [Abstract][Full Text] [Related]
12. The effect of high plasma levels of angiotensin-converting enzyme (ACE) and plasminogen activator inhibitor (PAI-1) on the reperfusion after thrombolytic therapy in patients presented with acute myocardial infarction.
El Menyar AA; Altamimi OM; Gomaa MM; Fawzy Z; Rahman MO; Bener A
J Thromb Thrombolysis; 2006 Jun; 21(3):235-40. PubMed ID: 16683215
[TBL] [Abstract][Full Text] [Related]
13. Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 levels in acute myocardial infarction.
Ganti AK; Potti A; Yegnanarayan R
Pathophysiol Haemost Thromb; 2002; 32(2):80-4. PubMed ID: 12214153
[TBL] [Abstract][Full Text] [Related]
14. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of plasminogen-activator-inhibitor-1 (PAI-1) levels in treatment with streptokinase of patients with acute myocardial infarction.
De Lorenzo F; Xiao H; Kakkar VV
Clin Cardiol; 2000 Dec; 23(12):877-8. PubMed ID: 11129670
[No Abstract] [Full Text] [Related]
16. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
[TBL] [Abstract][Full Text] [Related]
17. Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction.
Barbash GI; Hod H; Roth A; Miller HI; Rath S; Zahav YH; Modan M; Zivelin A; Laniado S; Seligsohn U
Am J Cardiol; 1989 Dec; 64(19):1231-5. PubMed ID: 2511742
[TBL] [Abstract][Full Text] [Related]
18. [t-PA in thrombolytic therapy of acute myocardial infarct].
Rutsch W; Schmutzler H
Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
[TBL] [Abstract][Full Text] [Related]
19. Captopril reduced plasminogen activator inhibitor activity in patients with acute myocardial infarction.
Moriyama Y; Ogawa H; Oshima S; Takazoe K; Honda Y; Hirashima O; Arai H; Sakamoto T; Sumida H; Suefuji H; Kaikita K; Yasue H
Jpn Circ J; 1997 Apr; 61(4):308-14. PubMed ID: 9152782
[TBL] [Abstract][Full Text] [Related]
20. Augmented platelet aggregation as predictor of reocclusion after thrombolysis in acute myocardial infarction.
Nordt TK; Moser M; Kohler B; Ruef J; Peter K; Kübler W; Bode C
Thromb Haemost; 1998 Dec; 80(6):881-6. PubMed ID: 9869154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
